Thermo Fisher to acquire Clario Holdings, the clinical trial data firm, for $8.9 billion in cash is in news and the same has been announced by the companies on October 29. Clario is at present held by a shareholder group that is led by Novo Holding, Astorg, Nordic Capital, and Cinven. Besides this, Thermo has also […]The post Thermo Fisher to Acquire Clario Holdings for $8.9bn first appeared on World Pharma Today.
